IFF Spotlights Pioneering Dietary Supplement Innovations at SupplySide . . . NEW YORK – Sept 27, 2023 — IFF’s Pharma Solutions and Health teams will showcase their extensive portfolios of next-level, plant-based dietary supplement solutions and innovative combination products that address some of today’s most in-demand health applications, at SupplySide West Expo in Las Vegas, Nevada, booth #3265
About Us - IFF Locations Macquarie Park, Australia Sydney, Australia; BDP Asia-Pacific (Australia) P L Unit 2 3 Helles Ave, Moorebank NSW 2170, Australia Moorebank NSW Australia
SleepScore Labs and IFF Innovate in Groundbreaking Sleep Partnership . . . Companies Collaborate to Create New World-Leading Consumer Sleep Products SleepScore Labs, the company behind the world’s most comprehensive suite of data-backed sleep solutions, today announced an unprecedented partnership with IFF, a leading innovator of taste, scent and nutrition ingredients, to create and validate products designed to support healthier lives through improved sleep
IFF Announces Launch of New IFF. com - IFF NEW YORK (Feb 13, 2025) —IFF (NYSE: IFF) today unveiled its newly redesigned corporate website, www iff com, marking a significant leap in scale, performance and commitment to top-tier digital experiences The revamped site offers a visually captivating and engaging journey, highlighting IFF’s leadership and the value it delivers across all the markets it serves
IBIE Event - IFF We create superior flavor, fragrance, food ingredient, and bioscience solutions rooted in science, inspired by nature and perfected through expertise and passion
Contact Us - IFF Contact us for inquiries, support, or to learn more about our innovative solutions
Our Science - IFF Discover how IFF harnesses biotechnology to convert renewable raw materials into the energy and products needed for society to thrive
About Us - Leadership at IFF Erik Fyrwald joined IFF as Chief Executive Officer in February 2024 Under his leadership, IFF has achieved significant milestones, including the successful divestiture of the Pharma Solutions business, the formation of key joint ventures such as Alpha Bio with Kemira, and the establishment of innovation hubs in China, Dubai and the United States